Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference

Vanda Pharmaceuticals Inc. -0.16%

Vanda Pharmaceuticals Inc.




WASHINGTON, May 30, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jefferies 2024 Global Healthcare Conference in New York City on Thursday, June 6, 2024. A corporate presentation is scheduled for 2:00 p.m. Eastern Time.

Vanda Logo (PRNewsfoto/Vanda Pharmaceuticals Inc.)

The corporate presentation given at the Jefferies 2024 Global Healthcare Conference may be accessed live on Vanda's corporate website, Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit and follow us on X @vandapharma.

Corporate Contact:

Kevin Moran

Senior Vice President, Chief Financial Officer and Treasurer

Vanda Pharmaceuticals Inc.


Jim Golden / Jack Kelleher / Dan Moore

Collected Strategies 

Cision View original content to download multimedia:

SOURCE Vanda Pharmaceuticals Inc.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via